Tauopathies
Showing 1 - 25 of 69
Tauopathies Trial in Philadelphia (Amyloid PET scan, Brain MRI Scan, Neurologic exam)
Recruiting
- Tauopathies
- Amyloid PET scan
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 14, 2023
Progressive Supranuclear Palsy, Corticobasal Syndrome Trial in San Francisco (Fasudil)
Active, not recruiting
- Progressive Supranuclear Palsy
- Corticobasal Syndrome
-
San Francisco, CaliforniaUniversity of California Weill Institute for Neurosciences
May 31, 2022
Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)
Active, not recruiting
- Tauopathies
- 11C-HY-2-15 PET
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 6, 2023
Human CNS Tau Kinetics in Tauopathies
Completed
- Progressive Supranuclear Palsy (PSP)
- +2 more
- 13C6 Leucine
-
Saint Louis, MissouriWashington University in St. Louis School of Medicine
Apr 12, 2022
Alzheimer, Dementia, Brain Diseases Trial in Farmington, Atlanta (Tele-Savvy, Caregiving During Crisis (Educational Program))
Active, not recruiting
- Alzheimer Disease
- +8 more
- Tele-Savvy
- Caregiving During Crisis (Educational Program)
-
Farmington, Connecticut
- +1 more
Dec 9, 2022
Alzheimer, Mild Cognitive Impairment, Dementia Trial in Montpellier, Nîmes, Perpignan (Measurement of amyloid and pTau blood
Recruiting
- Alzheimer Disease
- +3 more
- Measurement of amyloid and pTau blood biomarkers
-
Montpellier, Occitanie, France
- +2 more
Jun 29, 2022
Healthy Volunteers, Tauopathies, Alzheimer Trial in Long Beach (APNmAb005, Placebo)
Recruiting
- Healthy Volunteers
- +2 more
- APNmAb005
- Placebo
-
Long Beach, CaliforniaCollaborative Neuroscience Research, LLC., 2600 Redondo Ave.
Jun 1, 2022
Mild Cognitive Impairment (MCI), Alzheimer, Dementia Trial (XPro1595, Placebo)
Not yet recruiting
- Mild Cognitive Impairment (MCI)
- +8 more
- XPro1595
- Placebo
- (no location specified)
Aug 16, 2022
Alzheimer, Dementia, Brain Diseases Trial in Macquarie Park (XPro1595, Placebo)
Recruiting
- Alzheimer Disease
- +8 more
- XPro1595
- Placebo
-
Macquarie Park, New South Wales, AustraliaINmune Bio Investigational Site
Aug 15, 2022
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
Recruiting
- Alzheimer's Disease
- +8 more
- L-Leucine 13C6
-
Saint Louis, MissouriWashington University in Saint Louis
Apr 12, 2022
Alzheimer, Dementia, Brain Diseases Trial in Lexington (Harmony at HOME (H@H))
Recruiting
- Alzheimer Disease
- +8 more
- Harmony at HOME (H@H)
-
Lexington, KentuckyUniversity of Kentucky
Mar 21, 2022
Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan Trial (18F-PMPBB3 (APN-1607) PET imaging)
Recruiting
- Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
- 18F-PMPBB3 (APN-1607) PET imaging
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 24, 2022
Alzheimer's Disease, Cognitive Impairment, Tauopathies Trial in Worldwide (ACI-35.030, Placebo, JACI-35.054)
Active, not recruiting
- Alzheimer's Disease
- +6 more
- ACI-35.030
- +2 more
-
Helsinki, Finland
- +8 more
Jun 24, 2022
Parkinsonism Trial in Taoyuan City (F-18)
Completed
- Parkinsonism
-
Taoyuan City, Guishan Dist, TaiwanChang Gung Memorial Hospital,Linkou
Jan 25, 2021
Laryngopharyngeal Function in MSA, PD, and 4repeat Tauopathies
Recruiting
- Multiple System Atrophy
- +2 more
-
Innsbruck, Tirol, Austria
- +9 more
Sep 21, 2021
Healthy Volunteer, Alzheimer, Frontotemporal Dementia Trial in Seoul ([18F]PI-2620)
Completed
- Healthy Volunteer
- +3 more
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 11, 2020
Primary Four Repeat Tauopathies (4RT), Corticobasal Syndrome (CBS), Progressive Supranuclear Palsy (PSP) Trial in Birmingham,
Completed
- Primary Four Repeat Tauopathies (4RT)
- +3 more
- TPI 287 2 mg/m2
- +3 more
-
Birmingham, Alabama
- +1 more
Apr 13, 2020
Mild Cognitive Impairment, Alzheimer, Alzheimer Dementia Trial in Auckland (N-831(Traneurocin) 10 mg QD, NA-831 (Traneurocin) 20
Completed
- Mild Cognitive Impairment
- +9 more
- N-831(Traneurocin) 10 mg QD
- +3 more
-
Auckland, New Zealand
- +1 more
Jun 26, 2020
4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
Recruiting
- Corticobasal Degeneration (CBD)
- +5 more
- Observational Study
-
San Diego, California
- +7 more
May 18, 2021
Primary Tauopathies, Corticobasal Degeneration Syndrome, Frontotemporal Lobar Degeneration With Tau Inclusions Trial in San
Terminated
- Primary Tauopathies
- +5 more
- BIIB092
- Placebo
-
San Francisco, CaliforniaUCSF Memory and Aging Center
Dec 17, 2019
Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), Tauopathies Trial in New York (18F-AV-1451)
Completed
- Frontotemporal Lobar Degeneration (FTLD)
- +2 more
-
New York, New YorkMorton A. Kreitchman PET Center
Nov 18, 2019
Primary Tauopathy Corticobasal Degeneration Syndrome (CBD) Trial (ABBV-8E12)
No longer available
- Primary Tauopathy Corticobasal Degeneration Syndrome (CBD)
- (no location specified)
Aug 16, 2019
Alzheimer, Dementia, Brain Diseases Trial in Worldwide (Donanemab, Placebo)
Not yet recruiting
- Alzheimer Disease
- +8 more
- Donanemab
- Placebo
-
Brussels, Bruxelles-Capitale, Région De, Belgium
- +147 more
Aug 18, 2022
Predicted Tauopathies, Including, Progressive Supranuclear Palsy, Frontotemporal Dementia With Parkinsonism Linked to Chromosome
Completed
- Predicted Tauopathies, Including
- +4 more
- davunetide (AL-108, NAP)
- Placebo nasal spray
-
San Francisco, CaliforniaUniversity of California, San Francisco (UCSF)
Apr 3, 2019